LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

Home・Aktien・Vivani Medical

Vivani Medical

Geschlossen

1.44 21.01

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.15

Max

1.53

Schlüsselkennzahlen
By Trading Economics
Angestellte	37

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+214.96% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	12. Nov. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	3.7M 68M
Vorheriger Eröffnungskurs	-19.57
Vorheriger Schlusskurs	1.44

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Sept. 2025, 23:01 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid -- Update

17. Sept. 2025, 22:48 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid

17. Sept. 2025, 21:59 UTC

Ergebnisse

Cryptocurrency-Exchange Bullish Swings to Profit in First Report as Public Company

17. Sept. 2025, 23:44 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

17. Sept. 2025, 23:39 UTC

Market Talk

Gold Rises Amid Prospects of Further Fed Rate Cuts -- Market Talk

17. Sept. 2025, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Santos: XRG Consortium Wouldn't Agree to Appropriate Risk Allocation Between It and Santos Shareholders

17. Sept. 2025, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Santos: XRG Consortium Wouldn't Agree to Acceptable Terms That Protected Value of Transaction

17. Sept. 2025, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Had Expressed Concern to XRG Consortium About Delays in Agreeing to Scheme Implementation Agreement

17. Sept. 2025, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Santos: Consortium Notified Board of Decision to Withdraw Proposal on Weds Evening

17. Sept. 2025, 22:18 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Confirms XRG Consortium Has Withdrawn Takeover Proposal

17. Sept. 2025, 21:00 UTC

Ergebnisse

Darden Restaurants to Report Earnings. Why the Olive Garden Parent Is Expected to Stay Strong. -- Barrons.com

17. Sept. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

17. Sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. Sept. 2025, 19:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Sept. 2025, 19:59 UTC

Market Talk

Treasury Yields, Dollar Rise as Fed Cuts, Powell Warns of Risks -- Market Talk

17. Sept. 2025, 19:07 UTC

Market Talk

Oil Futures Snap Three-Session Winning Streak -- Market Talk

17. Sept. 2025, 18:43 UTC

Market Talk

Treasury Yields, Dollar Reverse Course as Powell Talks to Reporters -- Market Talk

17. Sept. 2025, 18:38 UTC

Market Talk

U.S. Natural Gas Futures Mixed Ahead of Storage Data -- Market Talk

17. Sept. 2025, 18:20 UTC

Market Talk

Gold Dips After Quarter-Point Rate Cut -- Market Talk

17. Sept. 2025, 18:18 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Sept. 2025, 18:18 UTC

Market Talk

Treasury Yields, Dollar Fall on Nearly Unanimous Fed Cut -- Market Talk

17. Sept. 2025, 18:14 UTC

Market Talk

Oil Slips Some More as Fed Makes Expected 25 Bp Rate Cut -- Market Talk

17. Sept. 2025, 17:59 UTC

Market Talk

Soyoil Takes Hit as Traders Consider EPA Proposal -- Market Talk

17. Sept. 2025, 17:15 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix 'Has Won The Streaming Wars,' Analyst Says. The Stock Is a Buy. -- Barrons.com

17. Sept. 2025, 17:06 UTC

Akquisitionen, Fusionen, Übernahmen

Walmart Stock Heads for a Record High. The Retailer Could Become a Leader in 'Agentic' AI. -- Barrons.com

17. Sept. 2025, 16:51 UTC

Ergebnisse

Correct: Exor 1H Net Loss -EUR624M

17. Sept. 2025, 16:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Sept. 2025, 16:34 UTC

Market Talk

Bank of Canada Ditches Resilience Talk, Plays Up Slowing Growth -- Market Talk

17. Sept. 2025, 16:25 UTC

Ergebnisse

Wolters Kluwer: July, August Saw a Slight Increase in Organic Growth Compared to 1H

17. Sept. 2025, 16:23 UTC

Ergebnisse

Wolters Kluwer: Year-to-Date Performance In Line With 2025 Guidance

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

214.96% Vorteil

12-Monats-Prognose

Durchschnitt 4 USD 214.96%

Hoch 4 USD

Tief 4 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.